SEC. 10. IMPROVING TREATMENT FOR PREGNANT AND 
POSTPARTUM WOMEN. 
Section 508(s) of the Public Health Service Act (42 
U.S.C. 290bb–1(s)) is amended in the first sentence by 
inserting before the period the following: ‘‘, and 
$100,000,000 for each of fiscal years 2019 through 
2023’’. 
SEC. 11. VETERANS TREATMENT COURTS. 
Section 2991(o)(3) of title I of the Omnibus Crime 
Control and Safe Streets Act of 1968 (34 U.S.C. 
10651(o)(3)) is amended— 
(1) by striking ‘‘LIMITATION’’ and inserting 
‘‘VETERANS’’; 
(2) by striking ‘‘Not more than’’ and inserting 
the following: 
‘‘(A) LIMITATION.—Not more than’’; 
(3) in subparagraph (A), as so designated, by 
striking ‘‘this section’’ and inserting ‘‘paragraph 
(1)’’; and 
(4) by adding at the end the following: 
‘‘(B) ADDITIONAL FUNDING.—In addition 
to the amounts authorized under paragraph (1), 
there are authorized to be appropriated to the 
Department of Justice to carry out subsection 
(i) $20,000,000 for each of fiscal years 2019 
through 2023.’’. 
VerDate Sep 11 2014 
20:49 Apr 02, 2018
Jkt 079200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H5311.IH
H5311
khammond on DSK30JT082PROD with BILLS
SEC. 12. INFANT PLAN OF SAFE CARE. 
Section 112 of the Child Abuse Prevention and 
Treatment Act (42 U.S.C. 5106h) is amended by adding 
at the end the following: 
‘‘(c) INFANT PLAN OF SAFE CARE.—In addition to 
amounts otherwise appropriated to carry out this title, 
there is authorized to be appropriated $60,000,000 for 
each of fiscal years 2019 through 2023, to provide funds 
for States to collaboratively develop policies and proce-
dures concerning, implement, and develop systems to mon-
itor plans of safe care under section 106(b)(2)(B)(iii).’’. 
SEC. 13. REQUIRE THE USE OF PRESCRIPTION DRUG MONI-
TORING PROGRAMS. 
(a) DEFINITIONS.—In this section: 
(1) 
CONTROLLED
SUBSTANCE.—The 
term 
‘‘controlled substance’’ has the meaning given the 
term in section 102 of the Controlled Substances 
Act (21 U.S.C. 802). 
(2) COVERED
STATE.—The term ‘‘covered 
State’’ means a State that receives funding under 
the Harold Rogers Prescription Drug Monitoring 
Program established under the Departments of 
Commerce, Justice, and State, the Judiciary, and 
Related Agencies Appropriations Act, 2002 (Public 
Law 107–77; 115 Stat. 748), under this Act (or an 
amendment made by this Act), or under the con-
VerDate Sep 11 2014 
20:49 Apr 02, 2018
Jkt 079200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H5311.IH
H5311
khammond on DSK30JT082PROD with BILLS
trolled substance monitoring program under section 
399O of the Public Health Service Act (42 U.S.C. 
280g–3). 
(3) DISPENSER.—The term ‘‘dispenser’’— 
(A) means a person licensed or otherwise 
authorized by a State to deliver a prescription 
drug product to a patient or an agent of the pa-
tient; and 
(B) does not include a person involved in 
oversight or payment for prescription drugs. 
(4) PDMP.—The term ‘‘PDMP’’ means a pre-
scription drug monitoring program. 
(5) PRACTITIONER.—The term ‘‘practitioner’’ 
means a practitioner registered under section 303(f) 
of the Controlled Substances Act (21 U.S.C. 823(f)) 
to prescribe, administer, or dispense controlled sub-
stances. 
(6) STATE.—The term ‘‘State’’ means each of 
the several States and the District of Columbia. 
(b) IN GENERAL.—Beginning 1 year after the date 
of enactment of this Act, each covered State shall re-
quire— 
(1) each prescribing practitioner within the cov-
ered State or their designee, who shall be licensed or 
registered healthcare professionals or other employ-
VerDate Sep 11 2014 
20:49 Apr 02, 2018
Jkt 079200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H5311.IH
H5311
khammond on DSK30JT082PROD with BILLS
ees who report directly to the practitioner, to consult 
the PDMP of the covered State before initiating 
treatment with a prescription for a controlled sub-
stance listed in schedule II, III, or IV of section 
202(c) of the Controlled Substances Act (21 U.S.C. 
812(c)), and every 3 months thereafter as long as 
the treatment continues; 
(2) the PDMP of the covered State to provide 
proactive notification to a practitioner when patterns 
indicative of controlled substance misuse, including 
opioid misuse, are detected; 
(3) each dispenser within the covered State to 
report each prescription for a controlled substance 
dispensed by the dispenser to the PDMP not later 
than 24 hours after the controlled substance is dis-
pensed to the patient; 
(4) that the PDMP make available a quarterly 
de-identified data set and an annual report for pub-
lic and private use, including use by health care pro-
viders, health plans and health benefits administra-
tors, State agencies, and researchers, which shall, at 
a minimum, meet requirements established by the 
Attorney General, in coordination with the Secretary 
of Health and Human Services; 
VerDate Sep 11 2014 
20:49 Apr 02, 2018
Jkt 079200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H5311.IH
H5311
khammond on DSK30JT082PROD with BILLS
(5) each State agency that administers the 
PDMP to— 
(A) proactively analyze data available 
through the PDMP; and 
(B) provide reports to law enforcement 
agencies and prescriber licensing boards de-
scribing any prescribing practitioner that re-
peatedly falls outside of expected norms or 
standard practices for the prescribing practi-
tioner’s field; and 
(6) that the data contained in the PDMP of the 
covered State be made available to other States. 
(c) NONCOMPLIANCE.—If a covered State fails to 
comply with subsection (a), the Attorney General or the 
Secretary of Health and Human Services may withhold 
grant funds from being awarded to the covered State 
under the Harold Rogers Prescription Drug Monitoring 
Program established under the Departments of Com-
merce, Justice, and State, the Judiciary, and Related 
Agencies Appropriations Act, 2002 (Public Law 107–77; 
115 Stat. 748), under this Act (or an amendment made 
by this Act), or under the controlled substance monitoring 
program under section 399O of the Public Health Service 
Act (42 U.S.C. 280g–3). 
VerDate Sep 11 2014 
20:49 Apr 02, 2018
Jkt 079200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H5311.IH
H5311
khammond on DSK30JT082PROD with BILLS